Zach Swarts

Chief Financial Officer at GbS Global Biopharma

Zach Swarts began his career as an auditor in the Las Vegas office of Ernst & Young, LLP. Mr. Swarts’ clients consisted primarily of SEC-registered companies in the highly regulated gaming industry in Nevada. After his departure from Ernst & Young, Mr. Swarts worked for a local public accounting firm as the Manager of the Litigation Support Department.

Mr. Swarts has now provided forensic accounting, expert witness, business valuation, and consulting services to clients in a wide variety of industries.

Mr. Swarts graduated from the University of Nevada at Las Vegas with a BSBA degree in Accounting. Mr. Swarts is also CPA-licensed in Nevada. In 2017, Mr. Swarts began employment with GB Sciences and served as the Director of Finance and Accounting for the two years prior to his appointment as the Chief Financial Officer in 2019.

Mr. Swarts brings both experience and dedication to his role in managing the finances at GB Sciences and preparing the Company’s audited corporate filings.

Timeline

  • Chief Financial Officer

    Current role